A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

(HealthDay News) — There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups, according to a study published online in the ...

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

As of mid-May, this variant has been identified in nearly 11% of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently assesses the ...

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy.

The patency rate at 6 months was higher for the silicone-coated metallic stent vs double-J stent. A silicone-covered metallic stent maintains patency better than a double-J stent in patients with ...

The pledge comes as the United States plans to leave the international organization, The Washington Post reported.

To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

The FDA has accepted for Priority Review the BLA for sibeprenlimab for the treatment of immunoglobulin A nephropathy in adults.